Abstract:Objectives Hyperprolactinemia has been proven to induce hypogonadism and metabolic derangements in both genders, while the consequences of prolactin (PRL) deficiency have been poorly investigated. The aim of the study is to systematically review and analyze data from clinical studies focusing on the metabolic consequences of abnormally high prolactin levels (HPRL) and low prolactin levels (LPRL). Methods A comprehensive systematic review was performed using Medline, Embase and Cochrane search. In particular, two separate literature searches (one for HPRL and one for LPRL) until 31 March 2022 for published English-language articles were performed. Results 17 studies were included in the analysis of HPRL. When compared to controls, patients with HPRL showed worse body composition. Moreover, higher total (12.55 [1.59-23.52] mg/dL p=0.02) and low-density lipoprotein (LDL)-cholesterol (13.40 [4.07-22.74] mg/dL p<0.001) as well as higher triglyceride levels (20.99 [9.36-32.63] mg/dL p<0.001) were observed in patients with HPRL. Finally, when glucose profile was analyzed, subjects with HPRL were characterized by higher HOMA index and insulin levels. Dopamino-agonist therapy resulted in an improvement of total (-19.26 [-25.22;-13.29] mg/dL p<0.001) and LDL cholesterol (-18.84[-24.44;-13.24] p<0.001) as well as triglyceride levels, fasting glycaemia and HOMA index. 12 cross-sectional and 3 longitudinal studies were included in the analysis of LPRL. Subjects included in cross-sectional studies, and with LPRL, showed worse lipid profiles and higher fasting glucose when compared to controls. The age-adjusted probability of diabetes was increased in subjects with LPRL (OR=1.60[1.43;1.79] p<0.001. Similar risk was observed when longitudinal studies were considered (OR=1.30[1.11;1.52] p<0.001 for LPRL vs. controls). Conclusions Pathological PRL elevation, but also its reduction, impairs metabolism and body composition in both genders, increasing the risk of diabetes. Patients with hypoprolactinemia, because of endogenous or iatrogenic conditions, deserve, as those with hyperprolactinemia, careful metabolic assessment. Conflicts of Interest The authors declare no conflict of interest.

Low prolactin levels are associated with visceral adipocyte hypertrophy and insulin resistance in humans

Increased Prolactin is an Adaptive Response to Protect Against Metabolic Disorders in Obesity

The relationship between low prolactin and type 2 diabetes

Serum prolactin levels were positively related to metabolic indexes and disorders in male obese patients

Association between serum prolactin levels and insulin resistance in non-diabetic men

Circulating Prolactin Level is Increased in Metabolically Healthy Obesity

The increase in prolactin was an adaptive response for protecting against metabolic disorders in obesity

Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome

(352) The Metabolic Role Of Prolactin: A Systematic Review And Meta-Analysis

Cardiometabolic effects of hypoprolactinemia

Evidence-based definition of hypoprolactinemia in European men aged 40–86 years: the European male ageing study

Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects

Cross-sectional Association Between Prolactin Levels and Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: a Retrospective Analysis of Patients from a Single Hospital in China.

Prolactin effects on the pathogenesis of diabetes mellitus

Circulating Prolactin Associates with Diabetes and Impaired Glucose Regulation A Population-Based Study

Metabolic and inflammatory parameters in relation to baseline characterization and treatment outcome in patients with prolactinoma: insights from a retrospective cohort study at a single tertiary center

The metabolic role of prolactin: systematic review, meta-analysis and preclinical considerations

Effect of Age, Gender, Food Intake, Obesity, and Smoking on Serum Levels of Prolactin in Healthy Adults

Lower Serum PRL is Associated with the Development of Non-Alcoholic Fatty Liver Disease: a Retrospective Cohort Study

What do we know about abnormally low prolactin levels in polycystic ovary syndrome? A narrative review

Maternal prolactin inhibition during lactation programs for metabolic syndrome in adult progeny